Insider screener

Period: 12 months Plan: Scheduled (10b5-1) × Share of holding: 50% or more × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

2,348 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

2,348 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

2,348 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

2,348 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
2,348 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
2,348 decisions over 12 months Remove this filter
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

2,348 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
6 Mar 2026
Kastelein Johannes Jacob Pieter Chief Scientific Officer · indirect
Sold on a plan
$2.85M 94,124 at 30.32
57.6%
Sold half or more
5 Mar 2026
DUFFIELD DAVID A 10% owner
Sold on a plan 5×
$15.82M 107,500 at 147.16
50.6%
Sold half or more
5 Mar 2026
Meaney William L President and CEO
Sold on a plan 3×
$10.48M 98,657 at 106.25
100%
Sold half or more
5 Mar 2026
ROTHBLATT MARTINE A Chairperson & CEO
Sold on a plan 9×
$4.60M 9,500 at 484.55
98.7%
Sold half or more
5 Mar 2026
Blake Sarah SVP, Chief Accounting Officer
Sold on a plan 3×
$3.55M 300,000 at 11.85
100%
Sold half or more
5 Mar 2026
Kastelein Johannes Jacob Pieter Chief Scientific Officer · indirect
Sold on a plan
$3.17M 104,467 at 30.30
60.1%
Sold half or more
5 Mar 2026
Davies Philip D VP Global Sales & Marketing
Sold on a plan 13×
$1.03M 5,419 at 189.67
73.8%
Sold half or more
5 Mar 2026
Zohar Shlomo Director
Sold on a plan 3×
$987.63K 22,029 at 44.83
53.7%
Sold half or more
5 Mar 2026
Shields Matthew EVP, Global Operations
Sold on a plan
$547.70K 17,295 at 31.67
63.4%
Sold half or more
5 Mar 2026
Jover Placid See "Remarks"
Sold on a plan
$448.11K 14,150 at 31.67
67.6%
Sold half or more
5 Mar 2026
Fitzpatrick Jennifer Chief Legal Officer
Sold on a plan
$347.02K 10,250 at 33.86
100%
Sold half or more
5 Mar 2026
Edmondson Frazor Titus III Chief Legal Officer
Sold on a plan
$296.75K 15,569 at 19.06
81.6%
Sold half or more
5 Mar 2026
Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER · indirect
Sold on a plan
$252.82K 3,989 at 63.38
59.3%
Sold half or more
5 Mar 2026
Pappis Charles C Director
Sold on a plan
$250.45K 5,000 at 50.09
100%
Sold half or more
5 Mar 2026
Holme Timothy CHIEF TECHNOLOGY OFFICER · indirect
Sold on a plan
$235.14K 34,254 at 6.86
100%
Sold half or more
4 Mar 2026
Venturo Brian M Chief Strategy Officer · indirect
Sold on a plan 5×
$22.31M 281,250 at 79.33
100%
Sold half or more
4 Mar 2026
Meaney William L President and CEO
Sold on a plan 2×
$10.59M 98,659 at 107.36
50.0%
Sold half or more
4 Mar 2026
Seidman Becker Caryn Chief Executive Officer · indirect
Sold on a plan 2×
$8.46M 174,324 at 48.51
100%
Sold half or more
4 Mar 2026
Sold on a plan 2×
$8.46M 174,324 at 48.51
100%
Sold half or more
4 Mar 2026
ROTHBLATT MARTINE A Chairperson & CEO
Sold on a plan 11×
$4.65M 9,500 at 489.91
98.7%
Sold half or more
4 Mar 2026
Ellis Andrea Director
Sold on a plan
$4.21M 64,921 at 64.87
77.7%
Sold half or more
4 Mar 2026
Tang Stanley Director · indirect
Sold on a plan 7×
$3.79M 21,449 at 176.77
100%
Sold half or more
4 Mar 2026
Daniell Richard EVP, Europe Commercial
Sold on a plan 3×
$2.98M 91,345 at 32.66
51.6%
Sold half or more
4 Mar 2026
ROTHBLATT MARTINE A Chairperson & CEO
Bought on a plan
$1.39M 9,500 at 146.03
×73
Bought on a plan
4 Mar 2026
Morris Shannon Chief Medical Officer
Sold on a plan
$300.76K 20,000 at 15.04
100%
Sold half or more
4 Mar 2026
Guyer William Chief Development Officer
Sold on a plan
$296.35K 8,233 at 35.99
78.7%
Sold half or more
4 Mar 2026
STETZ MATTIAS Chief Operating Officer · indirect
Sold on a plan 2×
$240.46K 11,892 at 20.22
100%
Sold half or more
4 Mar 2026
Ribeiro Ramiro Chief Medical Officer
Sold on a plan
$43.57K 2,438 at 17.87
100%
Sold half or more
4 Mar 2026
Theurer Nathan B. VP - Global Controller and CAO
Sold on a plan
$18.12K 92 at 196.95
100%
Sold half or more
3 Mar 2026
Seidman Becker Caryn Chief Executive Officer · indirect
Sold on a plan 3×
$10.02M 203,232 at 49.33
100%
Sold half or more
3 Mar 2026
Sold on a plan 3×
$10.02M 203,232 at 49.33
100%
Sold half or more
3 Mar 2026
BENNETT C FRANK EVP, Chief Scientific Officer
Sold on a plan 3×
$6.74M 85,089 at 79.23
51.4%
Sold half or more
3 Mar 2026
ROTHBLATT MARTINE A Chairperson & CEO
Sold on a plan 16×
$4.74M 9,500 at 499.42
98.7%
Sold half or more
3 Mar 2026
Diaz Allene M. Director
Sold on a plan 3×
$4.35M 54,878 at 79.35
93.5%
Sold half or more
3 Mar 2026
Daniell Richard EVP, Europe Commercial
Sold on a plan 2×
$4.17M 128,985 at 32.36
72.7%
Sold half or more
3 Mar 2026
Bialecki Andrew Co-Chief Executive Officer
Sold on a plan 2×
$3.73M 200,000 at 18.64
100%
Sold half or more
3 Mar 2026
Lopez-Baldrich Pedro J. Chief Legal Officer
Sold on a plan 4×
$2.78M 24,099 at 115.16
91.4%
Sold half or more
3 Mar 2026
Hughes Eric A See "Remarks"
Sold on a plan 2×
$2.61M 80,762 at 32.36
86.3%
Sold half or more
3 Mar 2026
Curet Myriam EVP & Chief Medical Officer · indirect
Sold on a plan
$2.30M 4,728 at 487.18
92.0%
Sold half or more
3 Mar 2026
KLEIN JOSEPH III Director
Sold on a plan 3×
$1.70M 21,332 at 79.51
65.9%
Sold half or more
3 Mar 2026
Craig Jonathan M. MD, Head of Investor Services · indirect
Sold on a plan 2×
$1.37M 14,481 at 94.60
100%
Sold half or more
3 Mar 2026
Sold on a plan
$735.07K 48,044 at 15.30
75.7%
Sold half or more
3 Mar 2026
STETZ MATTIAS Chief Operating Officer · indirect
Sold on a plan 2×
$596.73K 29,725 at 20.07
77.8%
Sold half or more
3 Mar 2026
Haaland Lynn GC & Chief Privacy Officer
Sold on a plan
$524.88K 11,064 at 47.44
60.0%
Sold half or more
3 Mar 2026
Handman Christopher T. SVP & General Counsel
Sold on a plan
$286.61K 2,999 at 95.57
50.0%
Sold half or more
3 Mar 2026
LARSON MATTHEW PAUL Chief Risk Officer
Sold on a plan
$213.86K 11,250 at 19.01
100%
Sold half or more
3 Mar 2026
Kapral Shane Deputy Chief Financial Officer
Sold on a plan
$136.70K 616 at 221.91
63.6%
Sold half or more
3 Mar 2026
Rodrigues Fernando M. President of BetterHelp
Sold on a plan
$124.98K 25,086 at 4.98
100%
Sold half or more
3 Mar 2026
Natali Chris SVP, Chief Accounting Officer
Sold on a plan
$98.76K 2,208 at 44.73
65.9%
Sold half or more
2 Mar 2026
Wirth Michael K Chairman and CEO
Sold on a plan 5×
$51.62M 272,624 at 189.35
89.7%
Sold half or more
Showing 1,351–1,400 of 2,348. ← Newer Page 28 of 47 Older →